Search results
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 1 day agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
William Blair Commentary- Large-Cap Growth: Managing Risk and Seeking Consistent Returns
GuruFocus.com via Yahoo Finance· 6 hours agoWhile large-cap companies in the biopharmaceutical industry may benefit from sizable revenue streams...
New York wins a share of $270M settlement against opioid manufacturer
Crain's New York Business· 4 days agoThe Bridgewater, New Jersey-based drug company was the largest manufacturer of generic opioids between 2006 and 2019, selling nearly ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 4 days ago, opens new tab said on Friday it had reached a deal valued at more than $270 million to resolve...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 11 hours agoGiven the dynamic and evolving nature of technology, the sector is perceived to be riskier than the ...
Generic Drug Giant Teva Hires New Legal Chief After DOJ Deal
Bloomberg Law· 7 days agoTeva Pharmaceutical Industries Ltd. has a new chief legal officer in David McAvoy, who succeeds David Stark as the top lawyer for the world’s largest generic drug manufacturer.
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters via AOL· 6 days agoThe drug distributor has been benefiting from specialty drugs and biosimilars - close copies of complex biotech drugs - at a time when intense competition pulls down prices ...
Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement - Amneal...
Benzinga· 4 days agoThis move positions Amneal as the latest pharmaceutical company to resolve lawsuits brought forth by...
New Drugs Won’t Help If They Can’t Reach Patients. My Family Learned the Hard Way.
Barrons.com· 16 hours agoChristine Schuster spent her life in healthcare. That wasn’t enough when her husband couldn’t get...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters via Yahoo News· 5 days agoDrug distributors, including rival Cencora, have been benefiting from growing sales of specialty medicines at a time when prices of generic, or copycat, ...